[News release] Psychedelic Drug Use Could Reduce Psychological Distress, Suicidal Thinking

Major rethink in order for some of us, including me? Or is the jury still out, so to speak. Perhaps a major rethink of some substances in light of the emerging role of personalized medicine.
Personal flashback to 1979 and Peace Corps training in Nashville TN. We were housed in motel rooms during our 1 1/2 month stateside training. One evening I returned to my room, where my two roommates were lounging. One told me the other was tripping on LSD (it had come to her on the back of the postage stamp from a mailed letter from a friend). Well, I about lost it, I had smoked (but not inhaled!) some marijuana once, but my perception of LSD was that it, well, took control of you and made you do things you wouldn’t normally do. The other roommate told me I just had to accept it. I said I didn’t have to and left the room for a few others and hung out with other volunteers. I was well, a bit scared that if the roommate was caught or reported, I could get kicked out of the Peace Corps program. Well, we never talked about the LSD, and had about 3 weeks to go in the program. And we all managed to get along fairly well after this incident. Stayed home while I attended college, so I guess this was a version of college roommate “drama”.

View image | gettyimages.com

 

From the 9 March 2015 Johns Hopkins news release

FAST FACTS:

• U.S. adults with a history of using some nonaddictive psychedelic drugs had reduced likelihood of psychological distress and suicidal thoughts, plans, and attempts, according to data from a nationwide survey.
• While these psychedelic drugs are illegal, a Johns Hopkins researcher and study author recommends reconsidering their status, as they may be useful in treating depression.
• Some people have serious adverse reactions to these drugs, which may not stand out in the survey data because they are less numerous than positive outcomes.

 

…

The observational nature of the study cannot definitively show that psychedelics caused these effects, Johnson says, because those who chose to use psychedelics may have been psychologically healthier before using these drugs. However, the results probably reflect a benefit from psychedelics — the study controlled for many relevant variables and found that, as the researchers expected, other drugs assessed in the study were linked to increased harms, he says. The use of nonaddictive psychedelic drugs may exacerbate schizophrenia or other psychotic disorders and can sometimes elicit feelings of anxiety, fear, panic and paranoia, which can lead to dangerous behavior, Johnson says. But these instances of individual harm, while serious, may not stand out in the survey data because they occur less often than the positive outcomes that some people experience.

“Our general societal impression of these drugs is they make people go crazy or are associated with psychological harm, but our data point to the potential psychological benefits from these drugs,” he says. Current research at Johns Hopkins and several other universities is examining the therapeutic potential of one of the psychedelics, psilocybin, when administered in carefully controlled, monitored medical studies.

Related article

No link between psychedelics and mental health problems

The use of psychedelics, such as LSD and magic mushrooms, does not increase a person’s risk of developing mental health problems, according to an analysis of information from more than 135,000 randomly chosen people, including 19,000 people who had used psychedelics. The results are published today in Journal of Psychopharmacology.

Nature and Lancet

Nature published a news item on this research yesterday, March 4: http://www.nature.com/news/no-link-found-between-psychedelics-and-psychosis-1.16968 Lancet Psychiatry will publish a companion letter to this study by Teri Krebs, “Protecting the human rights of people who use psychedelics.”

Few or no harms

Clinical psychologist Pål-&Ostroke;rjan Johansen (http://www.EmmaSofia.org) and neuroscientist Teri Krebs (Norwegian University of Science and Technology) used data from the US National Health Survey (2008-2011) to study the relationship between psychedelic drug use and psychological distress, depression, anxiety, suicidal thoughts, plans, and attempts. The researchers found no link.

Johansen and Krebs previous population study, which used data from 2001-2004, also failed to find evidence for a link between psychedelic use and mental health problems.

“Over 30 million US adults have tried psychedelics and there just is not much evidence of health problems,” says Johansen.

“Drug experts consistently rank LSD and psilocybin mushrooms as much less harmful to the individual user and to society compared to alcohol and other controlled substances,” adds Krebs. In contrast to alcohol, psychedelics are not addictive.

Possible benefits

Johansen and Krebs found that, on a number of measures, the use of psychedelic drugs is correlated with fewer mental health problems. “Many people report deeply meaningful experiences and lasting beneficial effects from using psychedelics,” says Krebs. However, “Given the design of our study, we cannot exclude the possibility that use of psychedelics might have a negative effect on mental health for some individuals or groups, perhaps counterbalanced at a population level by a positive effect on mental health in others,” adds Johansen.

Psychedelics and human rights

“With these robust findings, it is difficult to see how prohibition of psychedelics can be justified as a public health measure,” Johansen argues. Krebs adds that the prohibition of psychedelics is also a human rights issue: “Concerns have been raised that the ban on use of psychedelics is a violation of the human rights to belief and spiritual practice, full development of the personalty, and free-time and play.”

[Press release] Classic psychedelic use protective with regard to psychological distress and suicidality — ScienceDaily

 

Classic psychedelic use protective with regard to psychological distress and suicidality — ScienceDaily.

English: A bottle of LSD from a Swiss clinical trial for end-of-life anxiety in cancer patients, circa 2007, conducted by Dr. Peter Gasser, sponsored by the Multidisciplinary Association for Psychedelic Studies. The opaque bottle has a red cap and a yellow, cyan, and white label. The label says in part: Clinical Study, EK # 2007/016, d-LSD hydrate Capsule, Only for research purposes. (Photo credit: Wikipedia)
http://www.gettyimages.com/detail/81622620

Date:January 21, 2015

Source:SAGE Publications

Summary:Classic psychedelics, such as LSD, psilocybin mushrooms and mescaline, previously have been shown to occasion lasting improvements in mental health. But researchers, through a new study, wanted to advance the existing research and determine whether classic psychedelics might be protective with regard to suicidal thoughts and behaviors.

Classic psychedelics, such as LSD, psilocybin mushrooms and mescaline, previously have been shown to occasion lasting improvements in mental health. But researchers led by University of Alabama at Birmingham School of Public Health investigators wanted to advance the existing research and determine whether classic psychedelics might be protective with regard to suicidal thoughts and behaviors.

Approximately 30,000 lives in the United States are claimed by suicide every year, and more than 90 percent of victims have been diagnosed with mental illness, according to the National Alliance on Mental Illness.

Using data from more than 190,000 respondents of the National Survey on Drug Use and Health from 2008-2012, the researchers found that those who reported ever having used a classic psychedelic drug in their lifetime had a decreased likelihood of psychological distress in the past month, and decreased suicidal thinking, planning and attempts in the past year.

“Despite advances in mental health treatments, suicide rates generally have not declined in the past 60 years. Novel and potentially more effective interventions need to be explored,” said Peter S. Hendricks, Ph.D., assistant professor in the Department of Health Behavior and lead study author. “This study sets the stage for future research to test the efficacy of classic psychedelics in addressing suicidality as well as pathologies associated with increased suicide risk (e.g., affective disturbance, addiction and impulsive-aggressive personality traits).”

Hendricks says the take-home message from this study is that classic psychedelics may hold great promise in the prevention of suicide and evaluating the therapeutic effectiveness of classic psychedelics should be a priority for future research.

 

Related articles

• Using Psychedelic Drugs To Prevent Suicide
• Psychedelic use found to be protective with regard to psychological distress, suicidality
• Suicidal Thoughts, Psychological Distress Reduced In People Who Use LSD And Other Psychedelics
• LSD And Magic Mushrooms Ease The Mind, Reduce Suicidal Thoughts
• Classic psychedelic use protective with regard to psychological distress and suicidality
• Could Psychedelics Be An Effective Suicide Prevention Measure?
• State Suicide Rates, Death Totals
• Suicide And The Cost Of Life
• Conscious Student Alliance aims to spread mental health awareness
• The Other Sixties Revolution Has Unexpectedly Returned